Computational and experimental evaluation of curcumin as a DNMT3B-targeting epigenetic modulator in pancreatic cancer.

Afgar A, Zanganeh S, Mirzaee Khalilabadi R, Haghpanah T, Amopour Bahnamiry M, Ebrahimi H, Mirzaei-Parsa MJ, Kavyani B

Open source

DOI
10.1007/s40203-026-00717-1
Published
2026
Container
In silico pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40203-026-00717-1,
  title = {Computational and experimental evaluation of curcumin as a DNMT3B-targeting epigenetic modulator in pancreatic cancer.},
  author = {Afgar A and Zanganeh S and Mirzaee Khalilabadi R and Haghpanah T and Amopour Bahnamiry M and Ebrahimi H and Mirzaei-Parsa MJ and Kavyani B},
  year = {2026},
  journal = {In silico pharmacology},
  doi = {10.1007/s40203-026-00717-1},
  url = {https://doi.org/10.1007/s40203-026-00717-1}
}

RIS

TY  - JOUR
TI  - Computational and experimental evaluation of curcumin as a DNMT3B-targeting epigenetic modulator in pancreatic cancer.
AU  - Afgar A
AU  - Zanganeh S
AU  - Mirzaee Khalilabadi R
AU  - Haghpanah T
AU  - Amopour Bahnamiry M
AU  - Ebrahimi H
AU  - Mirzaei-Parsa MJ
AU  - Kavyani B
PY  - 2026
JO  - In silico pharmacology
DO  - 10.1007/s40203-026-00717-1
UR  - https://doi.org/10.1007/s40203-026-00717-1
ER  - 

APA

A, A., S, Z., R, M. K., T, H., M, A. B., H, E., MJ, M., & B, K. (2026). Computational and experimental evaluation of curcumin as a DNMT3B-targeting epigenetic modulator in pancreatic cancer.. In silico pharmacology. https://doi.org/10.1007/s40203-026-00717-1

Source records